🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Poland
Clinical trial register · Poland

Studies with a Polish investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2681 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2681
Studies in scope
all four open statuses
1400
Recruiting now
open to new participants
514
Lead sponsors
across recruiting studies
Top sites
Warsaw 1297 Krakow 869 Poznan 699 Gdansk 656 Lodz 622
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca160 Hoffmann-La Roche108 Merck Sharp & Dohme LLC103 Janssen Research & Development, LLC83 Eli Lilly and Company69
Site location
Warsaw1297 Krakow869 Poznan699 Gdansk656 Lodz622
All 261 locations
Target enrolment
to

Trials in this register

2681 of 2681 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation
NCT07809347Atrial Fibrillation (AF), Pulsed Field Ablation, Bradycardia
Wroclaw Medical University
Observational
100
Wroclaw
2026-01-01
By invitation
Comparison Between Velys J&J Robotic-assisted and Cori S&N Robotic-assisted Total Knee Arthroplasty
NCT07555067Knee Arthritis Osteoarthritis
Jan Biziel University Hospital No 2 in Bydgoszcz
Observational
200
Bydgoszcz
2026-01-01
Not yet open
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
NCT07203846ACS - Acute Coronary Syndrome, Ticagrelor, Microbiota, Platelet Aggregation
DrugRifaximin
Collegium Medicum w Bydgoszczy
Phase 4
50
Bydgoszcz
2026-01-01
Recruiting
Standardization of Variable Conditions of Embryo Transfer Into the Uterine Cavity in the Procedure of Medically Assisted Procreation in Humans
NCT07396181Infertility (IVF Patients), Infertility, ART
Przychodnia Lekarska nOvum Katarzyna Kozioł, Piotr Lewandowski sp.k.
Not applicable
200
Warsaw
2026-01-01
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Rzeszów, Warsaw, Wroclaw, Zabrze
2026-01-01
Recruiting
Vivinex Impress XY1-EM vs RayOne EMV
NCT06891092Cataract
Medical University of Bialystok
Not applicable
100
Bialystok
2026-01-01
Not yet open
GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.
NCT07345403Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury, Atrial Fibrillation (AF)
Medical University of Gdansk
Observational
3,000
Gdansk
2026-01-01
Recruiting
Large Language Models for Dental Radiology Report Generation From Structured Textual Data
NCT07676318Radiography, Oral Health, Large Language Model, Natural Language Processing (NLP)
Hospital of the Ministry of Interior, Kielce, Poland
Observational
100
Kielce
2026-01-01
Recruiting
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
NCT07529145Non-Small Cell Carcinoma of Lung, Small Cell Carcinoma of Lung
Medical University of Bialystok
Observational
90
Bialystok
2026-01-01
Not yet open
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
NCT07160959Chronic Kidney Disease (Stages 4 and 5), Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l.
Not applicable
124
Warsaw
2026-01-01
Recruiting
Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA
NCT07386600Knee Osteoarthritis
DrugsRopivacaine·Dexmedetomidine·Dexamethasone
Poznan University of Medical Sciences
Not applicable
96
Poznan
2026-01-01
Not yet open
Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms
NCT07371013Autism Spectrum Disorder, Gastrointestinal Symptoms
Institute of Mother and Child, Warsaw, Poland
Not applicable
20
Warsaw
2026-01
Not yet open
Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control
NCT07376850Diabetes, Diabetes (DM), Diabetes Type 1
University Hospital, Motol
Not applicable
120
Warsaw
2026-01
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357Untreated, Unresectable, or Metastatic Colorectal Cancer
DrugsFolfiri·Pumitamig·Folfox·Bevacizumab
Bristol-Myers Squibb
Phase 2/3
990
Krakow, Warsaw, Wieliszew, Opole, Brzozów, Gdansk, Gliwice, Koszalin
2025-12-31
Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
NCT07284979Obesity
DrugsRibupatide·Semaglutide
Kailera
Phase 3
1,200
Krakow, Warsaw, Gdynia, Chorzów, Bydgoszcz, Wroclaw, Kielce
2025-12-30
Recruiting
TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)
NCT07668869Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Glioblastoma Multiforme, Adult
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Not applicable
92
Bydgoszcz
2025-12-30
Recruiting
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
NCT07218523Bowel Cleansing Prior to Clinical Procedures
DrugPlenvu
Norgine
Phase 3
212
Torun, Krakow, Warsaw, Bialystok, Gdansk, Zabrze
2025-12-29
Active, closed
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
NCT07277660Atopic Dermatitis
DrugGalvokimig
UCB Biopharma SRL
Phase 2
165
Chorzów, Katowice, Krakow, Lodz, Sosnowiec, Tarnów, Warsaw, Wroclaw
2025-12-29
Recruiting
ACB With S-ESPB Versus ACB With iPACK for Knee Arthroplasty
NCT07288970Knee Osteoarthritis
Poznan University of Medical Sciences
Not applicable
80
Poznan
2025-12-25
Not yet open
Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
NCT07361666Basal Cell Carcinoma of Skin, Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Carcinoma in Situ (CSCCis), Cutaneous Squamous Cell Carcinoma of the Head and Neck
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Observational
400
Warsaw
2025-12-23
Active, closed
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199Lung Cancer, Adjuvant, Post-surgical, EGFR
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
360
Rzeszów, Olsztyn
2025-12-22
Recruiting
Identification of Biomarkers of Obstructive Sleep Apnea.
NCT07723144Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA), Obstructive Sleep Apnea (OSAS), Obstructive Sleep Apnea (SAOS)
Medical University of Bialystok
Not applicable
120
Bialystok
2025-12-19
Active, closed
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
NCT07225686Obesity, Obstructive Sleep Apnea
DrugMaridebart cafraglutide
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-12-19
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
NCT07294170Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis
DrugsEmpasiprubart·Efgartigimod
argenx
Observational
70
Bydgoszcz, Krakow, Katowice, Warsaw
2025-12-19
Active, closed
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT07311850Obesity and Overweight
DrugBerobenatide
Pfizer
Phase 3
3,578
Bialystok, Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Katowice, Krakow
2025-12-19
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
NCT07284420AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis, MG, gMG
DrugsEmpasiprubart·Efgartigimod
argenx
Phase 2
70
Bydgoszcz, Katowice, Warsaw
2025-12-19
Recruiting
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
NCT07284875Obesity, Overweight
DrugRibupatide
Kailera
Phase 3
2,340
Poznan, Torun, Krakow, Siedlce, Warsaw, Skierniewice, Zamość
2025-12-18
Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460Hemophilia
DrugsAntithrombin·Clotting factor concentrates·Fitusiran
Sanofi
Phase 3
85
Wroclaw
2025-12-18
Active, closed
Results Between Robotic-assisted and Manual Total Knee Arthroplasty With Kinematic Alignment
NCT07452809Knee Arthritis, Osteoarthritis
Jakub Błaszczyk
Not applicable
100
Bydgoszcz
2025-12-17
Recruiting
WATCHMAN FLX Pro European Registry
NCT07262255Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure
Boston Scientific Corporation
Observational
1,000
Poznan
2025-12-17
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969Major Depressive Disorder (MDD)
DrugDT-101
Draig Therapeutics Ltd
Phase 2
300
Gdansk, Katowice, Poznan
2025-12-16
Recruiting
Real-world Clinical Response to Trazodone in Italy, Poland, and Romania
NCT07377682Depression - Major Depressive Disorder, Cognition Disorders in Old Age
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
120
Lodz
2025-12-15
Recruiting
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
NCT07276581Rheumatoid Arthritis
AstraZeneca
Phase 2
320
Krakow, Torun, Warsaw, Wroclaw
2025-12-15
Recruiting
Post-traumatic Stress Disorder in Spontaneous Abortion
NCT07306676Spontaneous Abortion
Jagiellonian University
Observational
200
Krakow
2025-12-15
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600Overweight, Obesity
DrugEloralintide
Eli Lilly and Company
Phase 3
1,035
Bialystok, Bydgoszcz, Elblag, Krakow, Lodz, Lublin, Ruda Śląska, Zabrze
2025-12-15
Recruiting
Posttraumatic Stress Disorder in Ectopic Pregnancy
NCT07306689Ectopic Pregnancy
Jagiellonian University
Observational
200
Krakow
2025-12-15
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
NCT07221474Squamous Non-small Cell Lung Cancer
DrugsIntismeran autogene·Nab-paclitaxel·Paclitaxel·Carboplatin
Merck Sharp & Dohme LLC
Phase 2
180
Poznan, Warsaw, Przemyśl
2025-12-12
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site
DrugsPF-08634404·Bevacizumab
Pfizer
Phase 3
800
Katowice, Koszalin, Krakow, Opole, Poznan
2025-12-11
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Poznan, Warsaw, Lodz
2025-12-11
Recruiting
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
NCT07181590Paroxysmal AF, Atrial Arrhythmia, Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Warsaw
2025-12-11
Recruiting
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
NCT07214571Respiratory Syncytial Virus Infections
Shionogi
Phase 2
192
Tarnów, Chojncie, Ostrowiec Świętokrzyski
2025-12-11
Active, closed
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
NCT07228403Short Bowel Syndrome (SBS)
DrugGlepaglutide
Zealand Pharma
Phase 3
28
Skawina, Warsaw, Lodz
2025-12-11
Recruiting
Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery
NCT07474909Hand Injuries and Disorders, Wrist Sprain
Drugs0.9%NaCl·Dexamethasone
Poznan University of Medical Sciences
Not applicable
150
Poznan
2025-12-10
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
NCT07155187Non-Small Cell Lung Cancer
DrugsTelisotuzumab Adizutecan·Osimertinib
AbbVie
Phase 2/3
490
Poznan, Krakow, Warsaw, Gdansk, Sosnowiec
2025-12-10
Recruiting
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
NCT07290036Psoriatic Arthritis, Axial Spondyloarthritis
UCB Biopharma SRL
Phase 1
392
Bialystok, Bytom, Elblag, Krakow, Lodz, Lublin, Nowa Sól, Olsztyn
2025-12-10
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
DrugCYB003
Cybin IRL Limited
Phase 3
330
Bialystok, Bydgoszcz, Gdansk, Warsaw
2025-12-10
Recruiting
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943Choline Deficiency, Liver Injury
Protara Therapeutics
Phase 2/3
129
Lodz, Warsaw
2025-12-10
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
NCT07285213Clostridioides Difficile Infection
AstraZeneca
Phase 2
230
Lublin, Warsaw
2025-12-10
Recruiting
Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery
NCT07474896Osteoarthritis Shoulder
Poznan University of Medical Sciences
Not applicable
70
Poznan
2025-12-10
Recruiting
The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.
NCT07295782Uterine Prolapse, Urine Incontinence
Jagiellonian University
Observational
60
Krakow
2025-12-10
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779Ovarian Cancer
DrugINCB123667
Incyte Corporation
Phase 3
466
Bialystok, Gdansk, Kielce, Siedlce, Szczecin
2025-12-09
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945Chronic Kidney Disease
DrugDapagliflozin
Boehringer Ingelheim
Phase 3
120
Gdansk, Torun, Warsaw
2025-12-09
Recruiting
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
NCT07287189Duchenne Muscular Dystrophy, Duchenne, DMD, Neuromuscular Diseases
DrugSAT-3247
Satellos Bioscience, Inc.
Phase 2
51
Gdansk, Lodz
2025-12-08
Recruiting
Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]
NCT06466031Glioblastoma Multiforme
Copernicus Memorial Hospital
Not applicable
189
Lodz
2025-12-08
Recruiting
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
NCT06908304Carcinoma, Non-Small -Cell Lung
DrugsGemcitabine alone·Thiotepa·Taxotere·Vinorelbine
Maia Biotechnology
Phase 3
300
Poznan
2025-12-08
Recruiting
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
NCT07137598Rheumatoid Arthritis
DrugAfimkibart
Hoffmann-La Roche
Phase 2
160
Bytom, Elbl?g, Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2025-12-05
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
NCT07221253Biliary Tract Cancer
DrugsGemcitabine/Cisplatin·Rilvegostomig·Durvalumab
AstraZeneca
Phase 3
1,100
Koszalin, Krakow, Lodz, Olsztyn, Warsaw
2025-12-04
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
NCT07250802Plaque Psoriasis
DrugZasocitinib
Takeda
Phase 3
110
Wroclaw, Lublin, Rzeszów, Gdansk, Lodz
2025-12-04
By invitation
RVU120 Rollover Study
NCT06987058Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome
DrugsRVU120·Ruxolitinib
Ryvu Therapeutics SA
Phase 2
14
Chorzów, Gdansk, Katowice, Krakow, Wroclaw
2025-12-04
Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
NCT07209111Neoplasm Malignant
DrugsCalderasib·Cetuximab
Merck Sharp & Dohme LLC
Phase 2
150
Warsaw, Koszalin
2025-12-04
Recruiting
Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair
NCT07264699Inguinal Hernia Repair, Postoperative Pain, TAP Block
University of Warmia and Mazury in Olsztyn
Not applicable
100
Olsztyn
2025-12-04
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
NCT07276399Squamous Cell Carcinoma of Head and Neck
DrugsAmivantamab·Cisplatin·Carboplatin·Pembrolizumab
Janssen Research & Development, LLC
Phase 3
500
Gdansk, Gliwice, Lodz, Lublin, Poznan, Warsaw
2025-12-03
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
NCT07260877Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus)
Ventus Therapeutics U.S., Inc.
Phase 2
24
Bialystok, Oświęcim, Poznan, Rzeszów, Śląskie, Warsaw, Wroclaw
2025-12-03
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
NCT07218926Gastrointestinal Neoplasms
DrugsIDRX-42·Sunitinib
GlaxoSmithKline
Phase 3
450
Kielce, Poznan, Warsaw
2025-12-03
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT06979453Plaque Psoriasis
DrugDeucravacitinib
Bristol-Myers Squibb
Phase 3
366
Lublin, Warsaw, Bialystok, Gdansk, Lodz, Olsztyn
2025-12-03
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229Alzheimer Disease, Agitation
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
650
Poznan, Bydgoszcz, Chorzów, Katowice, Krakow, Lublin, Sochaczew, Wroclaw
2025-12-02
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281Atopic Dermatitis
DrugAbrocitinib
Pfizer
Phase 3
500
Lublin, Warsaw, Chorzów, Katowice, Lodz, Ostrowiec Świętokrzyski
2025-12-02
Not yet open
Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.
NCT07240389Vulvar Lichen Sclerosus
DrugsElidel·Clobetasol Propionate·Pimecrolimus
Milosz Pietrus
Not applicable
45
Krakow
2025-12-01
Not yet open
15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
NCT07237204Liver Cancer, Adult, Metastases to Liver, Liver Malignant Tumors
Medical University of Warsaw
Not applicable
600
Warsaw
2025-12-01
Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
DrugOrforglipron
Eli Lilly and Company
Phase 3
7,140
Bialystok, Bydgoszcz, Elblag, Krakow, Lodz, Lublin, Radom, Ruda Śląska
2025-12-01
Recruiting
Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.
NCT07278999Oral Lichen Planus, Erosive Lichen Planus, Mucosal Lesions
Medical University of Silesia
Not applicable
60
Zabrze
2025-12-01
Recruiting
fNIRS Neurofeedback for Post-stroke Hand Rehabilitation
NCT07262528Stroke
University of Rzeszow
Not applicable
30
Rzeszów
2025-12-01
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146Small-cell Lung Cancer
DrugZL-1310
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Lodz, Poznan, Przemyśl, Siedlce, Warsaw
2025-11-30
Recruiting
Pregnancy and Fibrin Clot Properties
NCT07275476Fibrin Blood Clot, Pregnancy, Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode
Jagiellonian University
Observational
100
Krakow
2025-11-28
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
NCT07166094Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
DrugRina-S
Genmab
Phase 3
660
Lublin, Siedlce, Bialystok, Szczecin, Kielce, Lodz
2025-11-28
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
NCT07236099Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
135
Bialystok, Gdansk, Kielce, Lodz, Malbork, Nowa Sól, Poznan, Rzeszów
2025-11-27
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
NCT06847542Neovascular Age-related Macular Degeneration
DrugRanibizumab
Hoffmann-La Roche
Phase 3
250
Krakow, Bielsko-Biala, Bydgoszcz, Gliwice, Lódz, Lublin, Olsztyn
2025-11-27
Recruiting
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
NCT07160608Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc.
Phase 2
75
Gdansk, Krakow, Poznan, Warsaw
2025-11-26
Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
NCT06930625Acromegaly
Debiopharm International SA
Phase 3
119
Bydgoszcz, Gliwice, Krakow, Poznan, Wroclaw
2025-11-26
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
NCT07227402Renal Cell Carcinoma
DrugsZanzalintinib·Belzutifan·Cabozantinib
Merck Sharp & Dohme LLC
Phase 3
904
Skórzewo, Bydgoszcz, Krakow, Siedlce, Warsaw, Przemyśl, Koszalin
2025-11-26
Recruiting
Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
NCT07258745Psoriasis
DrugSkyrizi
Chong Kun Dang Pharmaceutical
Phase 1
213
Warsaw
2025-11-26
Recruiting
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
NCT07195149Chronic Coronary Syndrome, Stable Coronary Artery Disease CAD
DrugsPrasugrel·Aspirin
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.
Phase 3
1,703
Bialystok, Bydgoszcz, Gdansk, Grudziądz, Katowice, Krakow, Lodz, Nowa Sól
2025-11-25
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT07155174Small Cell Lung Cancer
DrugsABBV-706·Lurbinectedin·Etoposide·Atezolizumab
AbbVie
Phase 2
180
Poznan, Lublin, Warsaw
2025-11-25
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531Type 1 Diabetes
SAb Biotherapeutics, Inc.
Phase 2
159
Opole, Poznan, Warsaw
2025-11-25
Recruiting
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
NCT07142291Amyotrophic Lateral Sclerosis (ALS)
DrugsCromolyn Sodium·Riluzole
PhenoNet, Inc.
Phase 2
105
Krakow, Warsaw
2025-11-25
By invitation
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT07256392Chronic Spontaneous Urticaria
DrugBarzolvolimab
Celldex Therapeutics
Phase 3
1,370
Bialystok, Częstochowa, Gdansk, Katowice, Krakow, Lublin, Oświęcim, Poznan
2025-11-25
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
NCT07226765Obstructive Sleep Apnea
DrugMaridebart cafraglutide
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-11-25
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
NCT07211958Acute Myeloid Leukemias
DrugRevumenib
Syndax Pharmaceuticals
Phase 3
468
Wałbrzych, Opole, Olsztyn
2025-11-25
Active, closed
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
NCT07217015Atopic Dermatitis
DrugKT-621
Kymera Therapeutics, Inc.
Phase 2
200
Chorzów, Gdansk, Gdynia, Krakow, Lublin, Rzeszów, Szczecin, Warsaw
2025-11-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310Parkinson's Disease
DrugPrasinezumab
Hoffmann-La Roche
Phase 3
900
Bia?ystok, Bydgoszcz, Gda?sk, Katowice, Krakow, Lublin, Oświęcim, Rzeszów
2025-11-24
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Koszalin, Lodz, Olsztyn
2025-11-24
Recruiting
Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty
NCT07347821Total Hip Arthroplasty (THA), Total Knee Arthroplasty (TKA), Hip Osteoarthritis, Knee Osteoarthristis
Medical University of Warsaw
Observational
1,000
Ostrów Mazowiecka
2025-11-22
Recruiting
Cardiovascular Assessment 5 Years After MIS-C
NCT07659847Multisystem Inflammatory Syndrome in Children (MIS-C), SARS-CoV-2 Infection
Medical University of Warsaw
Observational
90
Warsaw
2025-11-22
Recruiting
Vivatlac in Irritable Bowel Syndrome II (ViIBS2)
NCT07235215Irritable Bowel Syndrome
The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz
Not applicable
200
Jarocin
2025-11-21
Recruiting
Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients
NCT07235228Irritable Bowel Syndrome
The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz
Not applicable
20
Jarocin
2025-11-21
Recruiting
Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes
NCT07252778Sports Nutrition, Biochemical Markers, Exercise Performance, Aerobic Capacity
Krzysztof Durkalec-Michalski
Phase 2/3
30
Poznan
2025-11-20
Recruiting
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
NCT07593352IBD and Renal Involement, Chronic Kidney Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Observational
6,000
Warsaw
2025-11-20
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027Atopic Dermatitis, Eczema, Atopic
DrugPF-08049820
Pfizer
Phase 2
165
Krakow, Szczecin
2025-11-20
By invitation
Comparison Interventions on Kinetic and Kinematic Parameters
NCT07326475Young Football Players, Ankle Sprain Prevention
Medical University of Gdansk
Not applicable
45
Gdansk
2025-11-20
Rows per page Showing 401–500 of 2681
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-poland?page=5

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,681 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Poland?

1,400 of the 2,681 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 127 have not yet opened recruitment, 1,042 are active but closed to new participants, and 112 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (42) Heart Failure (41) Multiple Myeloma (39) Obesity (39) Ulcerative Colitis (33) Carcinoma, Non-Small-Cell Lung (28) Non-Small Cell Lung Cancer (28) Coronary Artery Disease (28) Crohn's Disease (27) Chronic Lymphocytic Leukemia (25) Atopic Dermatitis (23) Prostate Cancer (22) Non-small Cell Lung Cancer (21) Overweight (20) Systemic Lupus Erythematosus (20)
→

Browse trials by site location

Warsaw (1297) Krakow (869) Poznan (699) Gdansk (656) Lodz (622) Bydgoszcz (533) Wroclaw (521) Lublin (513) Katowice (499) Bialystok (384) Rzeszów (187) Szczecin (185) Olsztyn (183) Gdynia (167) Gliwice (122)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.